Posttranscriptional control of human homeobox gene expression in induced NTERA-2 embryonal carcinoma cells

• Published in: Molecular reproduction and development Vol. 1; no. 2; p. 107
• Main Authors: Simeone, A, Acampora, D, D'Esposito, M, Faiella, A, Pannese, M, Scotto, L, Montanucci, M, D'Alessandro, G, Mavilio, F, Boncinelli, E
• Format: Journal Article
• Language: English
• Published: United States 1989
• Subjects: Amino Acid Sequence; Animals; Base Sequence; Cell Differentiation - drug effects; Cell Differentiation - genetics; DNA - genetics; DNA Probes; Embryonal Carcinoma Stem Cells; Gene Expression Regulation - drug effects; Genes, Homeobox - drug effects; Humans; Molecular Sequence Data; Neoplastic Stem Cells - metabolism; RNA Processing, Post-Transcriptional; Sequence Homology, Nucleic Acid; Transcription, Genetic; Tretinoin - pharmacology; Tumor Cells, Cultured
• ISSN: 1040-452X; 1098-2795
• DOI: 10.1002/mrd.1080010205

We have studied the expression of four human homeobox genes representative of four different clusters (i.e., HOX-1, HOX-2, HOX-3 and HOX-5) in the embryonal carcinoma (EC) cell line NT2/D1. Following treatment with retinoic acid (RA), these cells differentiate into several cell types, including neurons, and steadily accumulate polyadenylated transcripts derived from the genes in a period ranging from 18 hr to 14 days of RA treatment. The sizes of major transcripts in differentiated EC cells coincide with those previously detected by the same probes in human embryos. Nuclear run-on transcriptional analysis showed no difference in the transcription rate of the four homeobox genes in differentiated vs. undifferentiated EC cells. Inhibition of protein synthesis by 5-18 hr of treatment of undifferentiated cells with cycloeximide causes accumulation of some homeobox transcripts at levels comparable to those observed after 18 hr of RA induction, although it does not cause superinduction in fully differentiated cells. These data suggest that the activation of homeobox gene expression in RA-induced EC cells is controlled, at least in part, by posttranscriptional mechanisms.